Cybin Inc. (CYBN) Financial Ratios
9 years of historical data (2017–2025) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↑
6.52
↓-71% vs avg
5yr avg: 22.17
30Y Low0.0·High60.3
ROE
↑
-42.8%
↓+92% vs avg
5yr avg: -504.6%
30Y Low-211%·High-29%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
CYBN Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Cybin Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $304M | $1.2B | $2.9B | $2.7B | $5.2B | $396 | $651M | — | — |
| Enterprise Value | $205M | $1.0B | $2.7B | $2.7B | $5.1B | $-1544604 | $649M | — | — |
| P/E Ratio → | -13.66 | — | — | — | — | — | — | — | — |
| P/S Ratio | — | — | — | — | — | 0.00 | — | — | — |
| P/B Ratio | 6.52 | 4.96 | 9.98 | 35.62 | 60.32 | 0.00 | 449.38 | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
CYBN EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — | -1.79 | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
CYBN Profitability
Margins and return-on-capital ratios measuring operating efficiency
A negative ROE of -42.8% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | 23.1% | — | — | — |
| Operating Margin | — | — | — | — | — | -3592.0% | — | — | — |
| Net Profit Margin | — | — | — | — | — | -3729.2% | — | — | — |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -42.8% | -42.8% | -42.4% | -49.3% | -163.1% | -2225.1% | -211.0% | -29.4% | -43.4% |
| ROA | -40.4% | -40.4% | -40.4% | -45.5% | -152.3% | -1883.1% | -183.4% | -23.7% | -28.7% |
| ROIC | -115.8% | -115.8% | -111.8% | -173.2% | -435.4% | — | — | — | — |
| ROCE | -54.1% | -54.1% | -42.8% | -63.1% | -144.0% | -2143.3% | -212.1% | -23.4% | -43.4% |
CYBN Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $135M exceeds total debt of $0, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | 0.00 | — | — | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.57 | -0.72 | -0.70 | -0.74 | -1.07 | -1.07 | -0.80 | -1.48 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | -3.90 | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | -264.89 | -3103.50 | — | — | — |
Net cash position: cash ($135M) exceeds total debt ($0)
CYBN Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Cybin Inc.'s current ratio of 7.75x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 7.38x to 7.75x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.75 | 7.75 | 21.65 | 7.38 | 13.57 | 6.24 | 6.24 | 23.32 | 2.88 |
| Quick Ratio | 7.75 | 7.75 | 21.65 | 7.22 | 13.61 | 6.24 | 6.24 | 23.32 | 2.88 |
| Cash Ratio | 6.30 | 6.30 | 20.70 | 6.78 | 13.07 | 5.87 | 5.87 | 23.02 | 2.88 |
| Asset Turnover | — | — | — | — | — | 0.50 | — | — | — |
| Inventory Turnover | 0.20 | — | — | 0.20 | — | 999999.00 | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | 561.44 | — | — | — |
CYBN Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Cybin Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $185M | $185M | $185M | $167M | $10 | $50M | $14M | $14M |
Peer Comparison
Compare CYBN with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 CYBNYou | $304M | -13.7 | — | — | — | — | -42.8% | -115.8% | — |
 CMPS | $896M | -3.0 | — | — | — | — | -565.3% | — | — |
 MNMD | $2B | -10.0 | — | — | — | — | -64.1% | -389.5% | — |
 ATAI | $962M | -4.3 | — | — | 100.0% | -33341.2% | -82.7% | -45.0% | — |
 SILO | $2M | -0.4 | — | — | 91.9% | -6526.4% | -78.4% | -186.7% | — |
 HALO | $8B | 25.7 | 8.4 | 12.0 | 78.1% | 58.4% | 153.6% | 73.4% | — |
 ENVB | $145840 | -0.0 | — | — | — | — | -539.6% | — | — |
 MAPS | $18M | 18.7 | -1.3 | 0.7 | 94.9% | 0.4% | 1.6% | 0.6% | 1.9 |
 INVA | $2B | 6.9 | 5.6 | 8.6 | 72.3% | 38.5% | 29.1% | 16.8% | — |
 NVAX | $1B | 3.1 | 3.0 | — | 93.5% | 40.3% | — | — | 0.5 |
 PRLD | $359M | -3.6 | — | — | 85.9% | -861.3% | -99.5% | -83.4% | — |
| Healthcare Median | — | 22.2 | 14.0 | 18.6 | 64.1% | -5.3% | -34.0% | -11.2% | 3.1 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 8 years · Updated daily
See CYBN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CYBN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CYBN vs CMPS
Side-by-side business, growth, and profitability comparison vs COMPASS Pathways plc.
Start ComparisonCYBN — Frequently Asked Questions
Quick answers to the most common questions about buying CYBN stock.
What is Cybin Inc.'s P/E ratio?
Cybin Inc.'s current P/E ratio is -13.7x. This places it at the 50th percentile of its historical range.
What is Cybin Inc.'s ROE?
Cybin Inc.'s return on equity (ROE) is -42.8%. The historical average is -83.1%.
Is CYBN stock overvalued?
Based on historical data, Cybin Inc. is trading at a P/E of -13.7x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.